# Infarct-associated oligoclonal T cell expansion in chronic experimental stroke across age, sex, and models.

- **DOI:** [10.1016/j.expneurol.2026.115878](https://doi.org/10.1016/j.expneurol.2026.115878)
- **Rating:** Sound (3.3 out of 5)
- **Verdict:** Clonotype-resolved multisite data establish chronic infarct repertoire skewing, but absent non-ischemic brain controls prevent specific attribution to infarct biology.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1016%2Fj.expneurol.2026.115878

## Key claims

1. Chronic infarct tissue consistently exhibited oligoclonal T cell expansion across age, sex, stroke models, and laboratories; spleen and blood remained broadly polyclonal.
   - Support: Tentative
   - Type: Primary finding
   - Basis: aged females lacked separate expansion and multisite validation was male-only, while non-ischemic brain controls were absent
   - Location: Abstract
2. Dominant clonotypes occupied a substantial fraction of the infarct repertoire, revealing a structured clonal architecture within the injured brain.
   - Support: Supported
   - Type: Secondary
   - Basis: top-ten clone analyses and mouse-level treemaps show marked dominance, though low-input repertoire depth may affect magnitude
   - Location: Abstract; Results, Figures 4 and 5
3. Computational annotation identified recurrent sequence similarities to self-associated TCRs, including receptors linked to myelin, nuclear, and insulin-related antigens, although many expanded clonotypes lacked database matches.
   - Support: Supported
   - Type: Secondary
   - Basis: similarity-based database matching supports descriptive associations but lacks a background null and cannot establish antigen specificity
   - Location: Abstract; Results, Figures 8–10
4. These findings demonstrate that chronic ischemic brain injury is associated with a reproducible, infarct-associated clonal T cell signature whose conserved architecture is consistent with antigen-driven selection, although stochastic or cytokine-driven expansion cannot be excluded.
   - Support: Tentative
   - Type: Secondary
   - Basis: bulk repertoires cannot distinguish antigen-driven selection from stochastic, homeostatic, or cytokine-driven expansion
   - Location: Abstract; Discussion

## Strengths

- **Clonotype resolution across diverse cohorts** The study combines an age-and-sex-stratified single-site cohort with TCRβ analyses across three stroke models and six institutions, extending earlier indirect repertoire measurements.
  - Dimension: contribution
  - Location: Materials and Methods, Experimental Design; Results, Figures 2 and 6
- **Bias controls and transparent methods** Animals were randomly assigned, samples were submitted under coded identifiers, the mouse was the analytical unit, and productive-rearrangement thresholds were reported.
  - Dimension: methodological rigour
  - Location: Materials and Methods, Animals; Immunosequencing and Clonality Analysis
- **Conservative antigen-annotation framing** Sequence similarities to curated antigen-associated TCRs are repeatedly described as hypothesis-generating rather than definitive evidence of specificity.
  - Dimension: reporting
  - Location: Abstract; Materials and Methods, In Silico Epitope Mapping; Discussion

## Limitations

- **Missing non-ischemic brain comparator** Comparisons with spleen and blood do not isolate an infarct-specific effect because those tissues differ markedly in T-cell abundance and composition. The Discussion acknowledges the absence of contralateral and other anatomical comparators.
  - Dimension: methodological rigour
  - Location: Results, Figures 2 and 6; Discussion, limitations paragraphs
- **Age-and-sex headline exceeds evidence** Aged female infarcts showed no separately detectable expansion, while the multisite validation cohort included only males. The abstract therefore generalises beyond the subgroup evidence.
  - Dimension: reporting
  - Location: Abstract; Results, Figures 2C and 3; Materials and Methods, Experimental Design
- **Mechanistic and translational gap remains** Bulk repertoire sequencing cannot establish paired receptors, antigen specificity, phenotype, causality, or therapeutic relevance, leaving the proposed adaptive-immune mechanism unresolved.
  - Dimension: application pathway
  - Location: Discussion, bulk-sequencing limitations and concluding paragraphs

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - Chronic infarct tissue consistently exhibited oligoclonal T cell expansion across age, sex, stroke models, and laboratories; spleen and blood remained broadly polyclonal: "Chronic infarct tissue consistently exhibited oligoclonal T cell expansion across age, sex, stroke models, and laboratories; spleen and blood remained broadly polyclonal." (Abstract) vs "In aged mice, infarct-associated clonal expansion was evident in males but not in females; however, when sexes were combined, infarct clonality remained significantly higher than spleen with no difference between aged male and female infarcts (Figure 2C)." (Results, T cell accumulation and clonal expansion within infarct tissue exhibit age- and sex-associated differences). Comparing the abstract's across-age-and-sex result with the subgroup Results shows that pooled aged-mouse significance does not establish separately detectable expansion in aged females. → Not supported by the paper's own data
- **Reporting and transparency:** Clean. No grounded reporting or transparency concern remains after checking the supplied concerns.
  - Conflict of interest: not stated · Ethics approval: declared · Preregistration: not stated · Data availability: declared · Code availability: not stated
- **Reference integrity:** Clean
  - 27 references in manuscript
  - 27 of 27 checkable references found in an index
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
